We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

91 hedge funds and large institutions have $406M invested in Calithera Biosciences, Inc in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 26

6% more capital invested

Capital invested by funds: $382M → $406M (+$24M)

3% less funds holding

Funds holding: 94 → 91 (-3)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

30% less call options, than puts

Call options by funds: $1.42M | Put options by funds: $2.04M

Holders
91
Holders Change
-3
Holders Change %
-3.19%
% of All Funds
2.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
35
Reduced
26
Closed
17
Calls
$1.42M
Puts
$2.04M
Net Calls
-$618K
Net Calls Change
+$1.18M

Top Buyers

Rank Fund Capital Flow
1
AQR Capital Management
AQR Capital Management
Connecticut
+$7.27M
2
American Century Companies
American Century Companies
Missouri
+$4.9M
3
Millennium Management
Millennium Management
New York
+$3.98M
4
State Street
State Street
Massachusetts
+$3.92M
5
AC
Ascend Capital
California
+$3.86M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.15M
3
BIM
Bogle Investment Management
Massachusetts
-$7.31M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3.67M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$2.18M +$147K +466 +7%
NI
27
Numeric Investors
Massachusetts
$2.17M +$2.18M +6,895 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.73M +$30K +95 +2%
Victory Capital Management
29
Victory Capital Management
Texas
$1.53M -$43.2K -137 -3%
Charles Schwab
30
Charles Schwab
California
$1.13M – – –
BCM
31
Bridgeway Capital Management
Texas
$1.07M -$939K -2,977 -47%
Morgan Stanley
32
Morgan Stanley
New York
$949K -$918K -2,911 -49%
Citigroup
33
Citigroup
New York
$912K +$245K +777 +37%
TA
34
Teachers Advisors
New York
$887K +$30.3K +96 +4%
PSUF
35
People's United Financial
Connecticut
$808K – – –
CAM
36
ClariVest Asset Management
California
$779K -$51.7K -164 -6%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$772K -$83.6K -265 -10%
USAA
38
United Services Automobile Association
Texas
$768K +$18.9K +60 +3%
NFA
39
Nationwide Fund Advisors
Ohio
$705K – – –
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$689K +$467K +1,481 +210%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$662K +$9.15K +29 +1%
UBS Group
42
UBS Group
Switzerland
$646K +$244K +772 +60%
GH
43
GAM Holding
Switzerland
$633K +$415K +1,315 +189%
FSA
44
Franklin Street Advisors
North Carolina
$560K +$15.8K +50 +3%
DTL
45
Dynamic Technology Lab
Singapore
$549K +$179K +568 +48%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$545K +$11.7K +37 +2%
BIM
47
Bogle Investment Management
Massachusetts
$535K -$7.31M -23,185 -93%
Wells Fargo
48
Wells Fargo
California
$531K +$109K +345 +26%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$515K – – –
CS
50
Credit Suisse
Switzerland
$494K -$13.2K -42 -3%
1
2
3 4 5

CALA Hedge Fund Activity: Q3 2017 in Review

91 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2017, worth a combined $406M — up 6.3% from $382M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CALA and 14 opened new positions — a net loss of 3 holders — while 26 trimmed existing stakes and 35 added.

The largest buyer was AQR Capital Management, adding an estimated $7.27M. The largest seller was Adage Capital Partners, cutting an estimated $10.6M.

  • 91 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2017, down from 94 in Q2 2017.
  • Funds reported $406M of Calithera Biosciences, Inc stock for Q3 2017, up 6.3% quarter-over-quarter.
  • 14 funds opened new Calithera Biosciences, Inc positions in Q3 2017 and 17 closed out, a net change of -3 holders.
  • The largest Calithera Biosciences, Inc buyer in Q3 2017 was AQR Capital Management, an estimated $7.27M added.
  • The largest Calithera Biosciences, Inc seller in Q3 2017 was Adage Capital Partners, an estimated $10.6M sold.

Based on aggregated 13F filings for Q3 2017.